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Heart rate variability (HRV) is utilised within laboratory and clinical settings as a non-invasive 
indicator of cardiac autonomic modulation.  Past research has utilised a wide variety of resting 
methodologies, and as such, it is difficult to draw conclusions on the nature of HRV from different 
studies.  Therefore, the current study aimed to assess the short-term stability of resting HRV during a 
40-minute resting trial and the impact of body position and gender on this short-term stability.  Resting 
HRV was determined from 40-minute trials in three standard positions (supine, seated, and standing) 
for healthy males (n=14) and females (n=16).  Time-domain, geometric, and frequency-domain 
measures of resting HRV were examined during consecutive 10-minute segments using a three-way 
ANOVA (time x position x gender) and Tukeys‟ post-hoc tests with reproducibility assessed by 
intraclass correlation coefficients (ICC) and coefficients of variation.  During rest, most HRV 
measures: fluctuated over time; were greater in the supine compared to the standing position; and were 
greater for males compared to females.  Variables that reflected primarily vagal modulations of heart 
rate remained stable whereas other HRV measures varied over time.  The majority of HRV variables 
exhibited substantial to excellent short-term reproducibility (ICC>0.6) with time-domain and geometric 
measures of HRV demonstrating greater values compared to frequency-domain parameters.  Based on 
the current results, the recording and analysis of HRV at 0-10 minutes of rest was recommended as a 
standardised protocol for the assessment of resting HRV in any standard position for either gender 
during laboratory and/or clinical settings. 
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Introduction 
Heart rate variability (HRV) has been investigated in a variety of settings including rest, exercise and 
various pathologies (Aubert et al. 2001; Kleiger et al. 1987; Leicht et al. 2003b; Task Force of the 
European Society of Cardiology and the North American Society of Pacing and Electrophysiology 
1996).  Most importantly, lower HRV has been associated with poor clinical outcome and increased 
morbidity and mortality (Tsuji et al. 1994), with HRV utilised as a prognostic and diagnostic clinical 
tool for assessing the autonomic modulation of heart rate (Fei et al. 1996).  The significant clinical 
value of HRV in a wide range of pathologies has led to subsequent investigation of the stability and 
reproducibility of HRV parameters. 
 
The majority of research investigating HRV stability or reproducibility has focussed on the long-term 
reproducibility; that is, the perturbations in HRV trials separated by days, weeks, months, and years.  
These studies have determined that, in general, HRV is reproducible over the long-term (days, weeks, 
years) (Tarkiainen et al. 2005; Van Hoogenhuyze et al. 1991).  Marks and Lightfoot (1999) 
investigated the long-term reproducibility of 2.5 and 5-minute recordings of HRV obtained from two 
trials within a one week period and determined that all time-domain variables were highly reproducible 
(ICC≥0.84), while frequency-domain variables were less reproducible (ICC range 0.67-0.96).  These 
investigators also determined that recording length did not significantly alter any of the investigated 
time-domain variables or some of the spectral measure of HRV (Marks and Lightfoot 1999).  In a 
review of HRV literature, HRV measures were shown to be moderately reproducible in a variety of 
resting situations, and that the duration of time between trials had little effect on reproducibility 
(Sandercock et al. 2005).  However, these findings were obtained in different population groups and 
with different resting protocols, leading Sandercock and colleagues (2005) to suggest that researchers 
needed to reconsider the available literature with regards to protocol, equipment, data analysis and 
population.   
 
To date, most studies investigating the reproducibility or stability of short-term measures of HRV have 
utilised the same protocol in each trial for comparison.  While this shows good scientific practice, most 
studies have conducted resting protocols of differing preparation and recording times, which has made 
comparisons between studies difficult (Leicht et al. 2003b; Sandercock et al. 2004; Tulppo et al. 1998; 
Yamamoto et al. 1991).  While HRV may be stable from day to day, and week to week, less is known 
about the within-recording stability.  Identification of this within-recording stability may allow for 
accurate comparisons between different populations and studies.   
 
Freed and colleagues (Freed et al. 1994) investigated two adjacent 10-minute recordings in patients 
prior to, and 10-hours following reconstructive knee surgery and determined that the frequency-domain 
parameters obtained were highly reproducible (correlation coefficients 0.74; coefficient of variation 
[CV] 15%).  However, the population in this study was diverse, including patients with heart disease, 
hypertension, and medicated patients (Freed et al. 1994).  Current HRV methodology guidelines (Task 
Force of the European Society of Cardiology and the North American Society of Pacing and 
Electrophysiology 1996) recommend that short-term measures of HRV be at least five-minutes in 
length to allow for accurate analysis of HRV variables.  However, these guidelines do not indicate 
when this recording should be determined within a resting protocol.  Rather the guidelines recommend 
only that the recordings be obtained during physiologically stable conditions (Task Force of the 
European Society of Cardiology and the North American Society of Pacing and Electrophysiology 
1996).  Consequently, this broad recommendation has resulted in a wide range of interpretations for 
“stable conditions” by researchers and numerous different protocols for resting HRV assessment 
(Leicht et al. 2003b; Sandercock et al. 2004; Tulppo et al. 1998; Yamamoto et al. 1991).  This lack of 
consistency for resting “stable conditions” makes it impractical to compare the results of different 
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studies and supports further the need for an examination of HRV short-term stability during rest. 
 
Therefore, the current study aimed to assess the short-term stability and reproducibility of resting HRV 
during a 40-minute resting trial and the impact of body position and gender on these measures.  Supine, 
seated, and standing resting positions were examined as these were the typical resting positions utilised 
for HRV examination, particularly for clinical investigations (Pomeranz et al. 1985; Sandercock et al. 
2004).  Gender was also examined as gender differences in HRV have been reported (Bigger et al. 
1995; Van Hoogenhuyze et al. 1991) with the impact of gender on HRV stability unknown.  Ten-
minute HRV recording lengths were examined in the current study due to their frequent use (Freed et 
al. 1994; Guijt et al. 2007; Marks and Lightfoot 1999; Sandercock et al. 2004) and in accordance with 
the current guidelines for HRV monitoring (Task Force of the European Society of Cardiology and the 
North American Society of Pacing and Electrophysiology 1996).   
 
 
Materials and Methods 
Participants 
Thirty (14 males, 16 females) healthy adults volunteered to participate in this study with their 
descriptive characteristics shown in Table 1.  Participants completed a general health pre-screening 
questionnaire and provided informed written consent prior to participation in accordance with the 
Declaration of Helsinki (2000) and approval by the local institutional Human Ethics Sub-committee. 
 
Design 
HRV data were assessed during 40-minute trials of three common resting positions (supine, seated, and 
standing rest) where the stability of resting HRV was assessed by comparing the data in consecutive 
10-minute segments.  Each resting position was examined on separate days and in a randomised order, 
following a 12-hour fast and a 24-hour abstinence from exercise.  Participants completed all trials at a 
similar time of day to minimise the known circadian rhythm of HRV (Fallen and Kamath 1995) with an 
average of 2.2  0.9 days separating each trial.  All trials were completed in a controlled environment 
within a climate control chamber of mean ( SD) temperature 24.6  0.5°C, and mean relative humidity 
52.8  2.7%.  As prior studies have reported equivocal results concerning the effect of the menstrual 
cycle on HRV (Leicht et al. 2003a; Sato et al. 1995), female participants in the current study completed 
their resting trials during the same phase of the menstrual cycle (days 16-28 after the first day of 
menses – luteal phase). 
 
Procedures 
Upon arrival at the laboratory, height was measured with a wall-mounted stadiometer (Seca, Hamburg, 
Germany), and mass was determined via bioelectrical impedance analysis (Tanita Corporation, Tokyo, 
Japan).  Body mass index (BMI) was calculated as mass/height in metres squared.  Three ECG 
monitoring electrodes (3M Australia Pty Ltd., Brisbane, Australia) were placed on prepared sites at the 
manubrium, left 5th intercostal space, and the right 5th/6th intercostal space for continuous ECG 
monitoring.  Following preparation, participants were given a 1-2 minute customisation period before 
the 40-minute trial began.  The single lead ECG (Lead II configuration) was sampled via a bioamplifier 
and Chart
®
 software (v5.5; AD Instruments Pty Ltd., Bella Vista, Australia) at a sampling rate of 1 
kHz.  Simultaneously with the ECG monitoring, respiratory gas analysis was conducted with expired 
gases being collected via a 2-way valve breathing mouthpiece (Hans Rudolph Inc., Kansas City, MO, 
USA) and sampled with an automated metabolic system (Powerlab 8M [AD Instruments Pty Ltd., Bella 
Vista, Australia] or Quinton [Quinton Instruments Co., Bothell, WA, USA]) calibrated according to the 
manufacturers guidelines.  Respiratory rate was not controlled in the current study as previous research 
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has reported similar reproducibility of HRV measures between spontaneous and controlled breathing 
(Hirsch and Bishop 1981; Zollei et al. 2007), and at various resting breathing frequencies (Patwardhan 
et al. 1995).  All ECG and respiratory data were stored for later analysis.   
 
Data Analysis 
Respiratory parameters were derived from the automated systems as 15-second averages for the 
following variables: tidal volume (TV), respiratory rate (RR), ventilation ( V E), and oxygen uptake 
( V O2).  Respiration rate and depth were monitored during each resting position with all participants 
exhibiting a steady breathing pattern. 
 
All ECG recordings were manually checked for missing and/or ectopic beats.  Ectopic beats were 
excluded from the HRV analysis and were replaced via linear interpolation of the prior and following 
normal RR intervals.  Each 10-minute segment of the 40-minute ECG recording was analysed using the 
HRV extension of Chart
®
 (v1.1; AD Instruments Pty Ltd., Bella Vista, Australia) for time-domain, 
frequency-domain and geometric measures of HRV (Table 2).  The frequency-domain components of 
HRV were obtained via power spectral analysis of the data using a 1024-point FFT with an overlap of 
50% for successive segments.  A Hanning window was applied to each spectrum to reduce spectral 
leakage.  All frequency domain components were expressed in absolute terms (ms
2
) while LF and HF 
were also expressed in normalised units (nu) and as a ratio (Table 2) (Task Force of the European 
Society of Cardiology and the North American Society of Pacing and Electrophysiology 1996). 
 
Statistical analysis 
Data were analysed using the Statistical Package for the Social Sciences (SPSS v17, SPSS Inc., 
Chicago, ILL).  Data normality was determined using the Kolmogorov-Smirnov statistic with a 
Lilliefors significance correction.  All HRV measures [except HR, LF (nu) and HF (nu)] and TV 
exhibited a non-normal distribution and subsequently were transformed using a natural logarithm (ln) 
prior to statistical analyses.  Significant differences between genders for descriptive characteristics 
were determined using independent t-tests or Mann-Whitney tests, where appropriate.  Significant 
differences between variables were examined using 3-way (time x position x gender) repeated 
measures ANOVA and Tukey‟s post-hoc tests. 
 
Reproducibility of HRV was determined via two statistical procedures: one-way random effects model 
ICC, as previously described (Zollei et al. 2007); and CV [CV=SD/mean] (Atkinson and Nevill 1998).  
Reproducibility was considered excellent for ICCs >0.80, and substantial when ICCs ranged between 
0.60 and 0.80 (Pinna et al. 2007), while a CV <10% was considered as acceptable (Atkinson and Nevill 
1998) for HRV reproducibility.  A p value <0.05 was set as the level of significance with all data 




Despite a similar age, males were significantly taller and heaver resulting in a greater BMI compared to 
females (Table 1). 
 
Influence of time 
The main effect of time on HRV is summarised in Figure 1.  Heart rate was stable until the final 10 
minutes of the 40-minute trial period, when it increased significantly (p=0.009, Table 2).  Of the time-
domain and geometric variables, SDΔNN, RMSSD, and SD1 were constant throughout the entire 
resting period (p>0.05), while both SDNN and SD2 increased significantly during the final 20 minutes 
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(p<0.001, Table 3).   
 
No significant effect of time was observed for the HF (ms
2
) component, however all other frequency-
domain variables exhibited significant changes over the 40-minute trial period (p<0.001, Table 3).  
Compared to the first 10 minutes of rest, TP, LF (ms
2
), LF (nu) and LF/HF were significantly increased 
during the final 20 mins of rest (Table 3).  VLF was significantly increased from 10-min onwards while 
HF (nu) was significantly lower after 20 minutes (Table 3).  Unlike HRV, all respiratory measures were 
similar across the 40-minute resting period (Table 3).  No significant interaction effects (i.e. time x 
gender, time x position x gender) were observed for any of the above HRV or respiratory variables. 
 
Influence of position 
Heart rate was significantly increased from supine through to standing rest with a corresponding 
significant decrease of all time-domain and geometric measures of HRV (p<0.001, Table 4).  A 
significant main effect for position was observed for all frequency-domain variables (p<0.001, Table 4) 
with TP, LF (nu), HF (ms
2
), HF (nu) and LF/HF measures significantly decreased from supine to 
seated rest, with a further significant decrease to standing rest.  Similarly, VLF and LF (ms
2
) were 
significantly reduced during standing rest, compared to supine and seated rest (Table 4).  No significant 
interaction effects (i.e. position x time, position x gender, position x time x gender) were observed for 
any of the HRV variables except for a significant position x time interaction effect for VLF (p=0.041, 
Table 5).  This interaction reflected a significantly lower VLF during standing compared to supine at 
each 10-minute period and greater VLF during the final 20 minutes of supine and seated rest (Table 5). 
 
Although TV was similar during all resting positions, RR, V E, and V O2 were significantly increased 
from supine and seated rest, to standing rest (p<0.001; Table 4).  No significant interaction effects (i.e. 
position x time, position x gender, position x time x gender) were observed for any of the HRV 
variables except for a significant position x time interaction effect for V E and V O2 (p=0.009 and p= 
0.036, Table 5).  Standing resulted in a significantly greater V E and V O2 compared to supine and 
seated rest at each 10-minute period while significantly lower V E was observed during the final 20 
minutes of supine rest (Table 5).   
 
Influence of gender 
Compared to females, males exhibited significantly greater SDNN, SD2, TP, VLF, LF (ms
2
), LF(nu), 
LF/HF and lower (p<0.06) HR and HF (nu) (Table 6).  Similarly, males exhibited greater TV, V E and 
V O2 compared to females (Table 6).  No significant interaction effects (i.e. gender x time, gender x 
position, gender x time x position) were observed for any of the variables. 
 
Reproducibility 
Most HRV and all respiratory variables demonstrated substantial to excellent reproducibility as 
assessed by ICC (p<0.001) for all resting positions and genders (Table 7).  Similarly, the CV for HR 
and most respiratory variables exhibited acceptable reproducibility (i.e. ≤ 10%) for all resting positions 
and genders (Table 7).  In contrast, the CVs for the time-domain and geometric variables were greater 
and ranged between 8.9 to 23.8%.  Similarly, the CV for the frequency domain variables were large 
and ranged between 7.1 and 53.6% (Table 7).  Of particular note was that the LF (nu) and HF (nu) 
variables exhibited lower CVs than the corresponding absolute measures of LF and HF (ms
2




The results of this study demonstrated that time-domain, geometric, and frequency domain measures of 
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HRV fluctuate over time and therefore were not stable during supine, seated, or standing rest.  
Significant position and gender effects were observed with greater HRV exhibited during supine rest 
and for males.  The reproducibility of the examined HRV variables was generally substantial (ICCs 
>0.6) with the time-domain and geometric measures of HRV demonstrating greater reproducibility 
(higher ICCs and lower CVs) compared to the frequency domain parameters.  The lack of HRV 
stability during rest in the current study raises concerns about current resting methodologies and 
confirms the need for a standardised resting HRV protocol to be used in conjunction with the current 
HRV guidelines (Task Force of the European Society of Cardiology and the North American Society of 
Pacing and Electrophysiology 1996) for comparison of HRV between studies. 
 
As demonstrated in Figure 1, HRV parameters were variable throughout the 40-minute resting period.  
The HRV measures reported to reflect vagal modulations of HR [i.e. SDΔNN, RMSSD, SD1, and HF 
(ms
2
)] (Task Force of the European Society of Cardiology and the North American Society of Pacing 
and Electrophysiology 1996) were similar throughout the 40-minute rest recording while variables 
influenced by sympathetic and/or other physiological modulations such as SDNN, TP, LF (ms
2
), LF 
(nu) and LF/HF (Task Force of the European Society of Cardiology and the North American Society of 
Pacing and Electrophysiology 1996) were significantly increased 20-minutes into the recording.  The 
frequency-domain measures of HRV provide a key insight into the physiological and neural influence 
of HR control, particularly within short-term recordings (Task Force of the European Society of 
Cardiology and the North American Society of Pacing and Electrophysiology 1996).  Although 
stability in the HF component suggests that vagal influence on HR was unchanged over the recording 
period, TP which reflects primarily vagal modulations (Task Force of the European Society of 
Cardiology and the North American Society of Pacing and Electrophysiology 1996) was significantly 
increased, most likely due to an increased LF power and a larger increase in VLF power.  Since the LF 
component has been suggested as an indicator of vagal and sympathetic modulation of HR (Akselrod et 
al. 1981; Akselrod et al. 1985; Pomeranz et al. 1985), it is reasonable to conclude that sympathetic 
activity may have increased over the 40-minute trial period.  In a study examining the effect of mental 
stress on HRV, it was cautioned that an increased LF component may not be reflective of sympathetic 
activity, but by alterations in breathing frequencies associated with various tasks (Bernardi et al. 2000).  
However, this was unlikely in the current study as RR remained stable over the whole 40-minute period 
(Table 3).  Further, the reproducibility of these respiratory parameters was observed to be excellent 
(ICCs >0.85; CVs ranging between 5.3 and 11.0%).  Additionally, changes in arterial pressure with 
enhanced baroreflex activity are also known to affect the LF component of HRV (Akselrod et al. 1981) 
and may have impacted on HRV in the current study however, blood pressure was not monitored and 
this remains to be examined in future studies. 
 
More difficult to explain was the observed increase in the long-term HRV measures (e.g. VLF).  Since 
vagal influence was demonstrated to remain stable (i.e. HF power was unchanged over time), other 
factors may contribute significantly to the increased VLF.  It seems unlikely that the increase in VLF 
was a result of thermoregulatory system fluctuations (Kitney 1977) since all trials were completed in a 
constant thermoneutral environment.  Similarly, the steady environment and the inclusion of only 
healthy participants into the study suggest that the increased VLF was not a result of a change in 
peripheral chemoreceptor sensitivity (Ponikowski et al. 1996).  Possible changes in renin-angiotensin 
system (RAS) activity (Akselrod et al. 1981; Akselrod et al. 1985) and/or parasympathetic activity at 
very low frequencies (Taylor et al. 1998) may have contributed to the enhanced VLF.  Greater VLF 
during the last 20 mins of supine and seated rest, to a level greater than that evident during standing 
(Table 4), may suggest reduced RAS in response to reduced baroreflex activity (Akselrod et al. 1981; 
Akselrod et al. 1985) during supine and seated rest.  Subsequently, reduced RAS activity may attenuate 
the inhibitory effect of Angiotensin II on the sino-atrial node increasing the very low vagal oscillations 
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and HRV (i.e. VLF).  However, the influence of RAS activity and blood pressure changes remains to 
be confirmed as blood pressure was not monitored in the current study.  Future examination of 
simultaneous HR and BP may give further insight into the role of the VLF component and its 
physiological mechanisms in regulating HRV stability during rest. 
 
The aims of the current study were to examine the short-term stability of resting HRV and the impact 
of body position and gender on HRV stability.  While HRV fluctuated over time, HRV magnitude 
rather than reproducibility was influenced by position and gender.  In line with previous reports, HRV 
was significantly decreased from supine to seated rest, and further decreased during standing rest 
(Pomeranz et al. 1985).  Despite the absolute reduction in HRV with resting position, reproducibility as 
assessed by ICC and CV was similar for each position (Table 7) and suggests that HRV can be 
consistently assessed during different resting positions, albeit the same resting position.  Similarly, 
HRV reproducibility was comparable for males and females (Table 7) despite significantly greater 
HRV for males (Table 6).  Evidence from studies suggesting HRV differences between genders has 
been debatable with several studies reporting no significant differences in HRV between male and 
female healthy subjects (Sinnreich et al. 1998).  Others have observed a significantly greater HRV in 
healthy male subjects (Bigger et al. 1995; Van Hoogenhuyze et al. 1991).  Lower HRV for females has 
been suggested to possibly reflect gender comparisons at different menstrual cycle stages (Leicht et al. 
2003a) with greater sympathetic activity and lower parasympathetic activity reported during the luteal 
phase compared with the follicular stage (Saeki et al. 1997; Sato et al. 1995).  However, this seems 
unlikely in the current study as HRV was reported to be similar at times of high and low ovarian 
hormonal influence in young healthy females (Leicht et al. 2003a).  Regardless, the similar HRV 
stability for males and females, suggests that HRV can be consistently assessed for males and females, 
albeit separately.  
 
The reproducibility of HR in the current study was excellent (ICCs>0.9, CVs <4%, Table 7) during all 
resting positions for males and females.  Similarly, most HRV variables demonstrated substantial 
reproducibility for all resting positions in terms of ICCs (>0.6).  Kowalewski and Urban (2004) 
obtained multiple (though not adjacent) 10-minute recordings of HRV during same-day recordings and 
reported ICCs ranging from 0.54-0.89 in the supine positions, and 0.68-0.91 in the standing positions 
for TP, LF, HF, and the LF/HF.  Likewise, the current study demonstrated similar ICCs ranging from 
0.721-0.931 for these variables in the supine position and 0.546-0.933 in the standing position.  
However, the current study‟s CV was rather large, particularly for the frequency-domain measures 
(Table 7).  Notably, those measures of HRV that reflected vagal modulation of HR generally exhibited 
better ICCs than the other variables (e.g. 0.820-0.956 during supine rest for SDΔNN, RMSSD, SD1, 
and HF; compared to 0.699-0.865 for all other variables during supine rest).  Further, the CVs of time 
and frequency-domain variables in the current study were greater than that reported for patients with 
CAD, MI and hypertension (e.g. ~20-41% vs. 9-15%) (Freed et al. 1994; Tarkiainen et al. 2005).  The 
healthy population utilised in the current study may account for the differences in CVs as these young, 
healthy, active participants exhibited greater HRV and potentially greater variability of HR and HRV 
(both within- and between-participants).  Similar large CVs in healthy children with high HRV and 
developing neural systems (Leicht and Allen 2008) further support the notion that large CVs for HRV 
may in fact be typical in healthy populations with high HRV.  In contrast, lower CVs exhibited by 
patients with cardiovascular disease (Freed et al. 1994; Tarkiainen et al. 2005) may be a result of low 




It should be noted that the current results were limited to healthy, young, active adults.  To our 
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knowledge, short-term stability of HRV and the requirement for a standardised resting protocol for 
other populations, including youths, elderly and those suffering from cardiological or non-cardiological 
disease, remains to be confirmed. 
 
Recommended standardised protocol 
Within the current study, HRV did not remain consistent during rest and makes it difficult to compare 
results from different studies utilising different resting protocols.  Subsequently, a standardised resting 
protocol may be beneficial to allow direct comparison between studies.  Based on the current results, 
we would suggest that HRV be assessed at 0-10 minutes of rest.  Although most variables were stable 
during the final 10 minutes of the recording, this period was deemed unsuitable because of a significant 
increase in HR.  Similarly, the 10-20 and 20-30 minute segments were excluded due to increases of the 
VLF and/or other HRV measures (Table 3, Figure 1).  For the purposes of clinical evaluation, the 0-10 
minute segment provides the most time efficient option however, it could be debated as to whether this 
segment is truly reflective of a resting state.  Gujit and colleagues (2007) compared 10 minutes of 
supine rest (following a five-minute acclimatisation period) to the second hour of an ambulatory night 
recording and found significant differences between the two.  Their recommendation was that caution 
needed to be used within the laboratory, as a laboratory-based protocol may not necessarily reflect a 
true resting state.   
 
In the current study, most HRV variables had reached peak values by the 20-30 minute period that may 
indicate this timeframe as the most suitable for the recording of HRV and a similar resting state to that 
of night-time recordings, particularly in terms of the VLF component.  However, this timeframe should 
be considered cautiously as HF (nu) and LF/HF were also significantly altered indicating possibly 
enhanced sympathetic modulations (Task Force of the European Society of Cardiology and the North 
American Society of Pacing and Electrophysiology 1996).  Identification of the physiological 
mechanisms responsible for the increased HRV during the 20-30 minute segment of the current study is 
particularly important since VLF has been suggested as a powerful predictor of cardiac events (Hadase 
et al. 2004).  Further research examining HRV with the assessment of blood pressure may assist in 
determining whether blood pressure variability influences the observed increases in LF and VLF, and 
may clarifying if the 20-30 minute timeframe is an appropriate period for „stable resting HRV‟ 
measurements. 
 
The current study determined that some short-term HRV parameters do not remain constant during 
normal resting conditions although they exhibit substantial reproducibility for supine, seated and 
standing positions for males and females.  It was recommended that HRV (10-minute recording) be 
assessed during 0-10 minutes in any standard resting position (i.e. supine, seated, standing) for both 
males and females.  Use of this standardised resting protocol will enable comparison of short-term 
HRV between studies as a valid research and clinical tool. 
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Age (yr)           24.2  5.9           24.9  7.8           24.6  6.9 
Height (cm)         180.9  6.8         165.9  8.3***         172.9  10.7 
Mass (kg)           79.8  10.9           59.4  8.8***           68.9  14.2 
BMI (kg·m-2)           24.3  2.8           21.5  2.1**           22.8  2.8 
**p<0.01, ***p<0.001 vs. Male 
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Table 2  Time and frequency domain measures of heart rate variability assessed in the current study. 
Measure Description* 
SDNN Standard deviation of all normal-normal RR intervals 
SDΔNN Standard deviation of the change in all normal-normal RR intervals 
RMSSD The root mean square of successive differences in normal-normal RR intervals 
SD1 Standard deviation of instantaneous RR variability (i.e. short axis of Poincare plot) 
SD2 Standard deviation of long-term RR variability (i.e. long axis of the Poincare plot, 
VLF Spectral power located within the very low frequency range (0-0.04 Hz) and represents 
modulations of the parasympathetic and sympathetic nervous systems, the renin-
angiotensin system, the thermoregulatory system, and chemoreflex sensitivity (Akselrod 
et al. 1985; Ponikowski et al. 1996) 
LF Spectral power located within the low frequency range (0.04-0.15 Hz) and reflects 
modulations of the parasympathetic and sympathetic nervous systems including 
baroreflex activity (Akselrod et al. 1981) 
HF Spectral power located within the high frequency range (0.15-0.4 Hz) and predominately 
reflects modulations of the parasympathetic nervous system (Akselrod et al. 1981) 
TP Spectral power located within the total frequency range (0-0.4 Hz) 
LF/HF Ratio of LF to HF and indicator of sympathovagal balance 
*(Task Force of the European Society of Cardiology and the North American Society of Pacing and 
Electrophysiology 1996)
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Table 3  Heart rate variability and respiratory variables during consecutive 10-minute resting periods 
(n=30). 
 Time (minutes) 
 0-10 10-20 20-30 30-40 
HR (bpm) 68.3  15.5 69.0  15.7 69.2  15.6 70.0  16.5* 
SDNN (ms) 77.6  32.3 82.0  36.8 87.6  36.8** 88.5  38.3** 
SDΔNN (ms) 66.4  47.7 66.6  49.2 67.6  47.0 64.9  43.2 
RMSSD (ms) 66.4  47.6 66.5  49.1 68.2  46.1 64.9  43.1 
SD1 (ms) 47.0  33.7 47.1  34.8 47.8  33.2 45.9  30.5 
SD2 (ms) 97.7  35.5 104.6  42.4 112.9  43.7** 115.4  47.5**†† 
TP (ms2) 6661  6238 8049  8181 8826  7756** 8673  7768** 
VLF (ms2) 1847 1393 2818  3037** 3558  3334**† 3436  3531** 
LF (ms2) 2038  2063 2393  2661 2585  2504** 2731  2744** 
LF (nu) 52.29  22.74 54.81  21.59 57.5  20.95** 58.25  21.10** 
HF (ms2) 2654  4455 2586  4984 2528  4130 2362  3229 
HF (nu) 44.75  22.36 41.92  21.17 39.49  20.79** 38.79  20.74** 
LF/HF 2.42  3.63 2.58  3.71 2.76  3.64** 3.03  4.05** 
TV (L) 0.69  0.34 0.69  0.35 0.69  0.35 0.70  0.34 
RR (breaths·min-1) 14.4  4.0 14.4  4.0 14.4  3.7 14.0  3.6 
V E (L·min-1) 7.78  2.33 7.64  2.54 7.61  2.60 7.60  2.51 
V O2 (mL·kg-1·min-1) 4.20  1.03 4.15  1.19 4.17  1.28 4.22  1.28 




p<0.01 vs. 10-20; HR, heart rate; SDNN, 
standard deviation of RR (NN) intervals; SDΔNN, standard deviation of the change in RR intervals; RMSSD, 
square root of the mean squared differences of successive RR intervals; SD1, standard deviation of instantaneous 
RR variability; SD2, standard deviation of long-term RR variability; TP, total power; VLF, very low frequency; 
LF, low frequency; nu, normalised units; HF, high frequency; LF/HF, low frequency to high frequency ratio; 
TV, tidal volume; RR, respiratory rate; V E, ventilation; V O2, oxygen uptake. 
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Table 4  Heart rate variability and respiratory variables during supine, seated, and standing resting 
positions (n=30). 
 Supine Seated Standing 
HR (bpm) 58.0  9.8 67.0  10.6** 82.3  15.5**†† 
SDNN (ms) 105.9  37.6 85.4  30.1** 60.4  24.4**†† 
SDΔNN (ms) 103.9  51.6 62.7  28.9** 32.5  21.5**†† 
RMSSD (ms) 103.6  51.4 62.7  28.9** 33.2  22.1**†† 
SD1 (ms) 73.5  36.5 44.4  20.4** 23.0  15.2**†† 
SD2 (ms) 129.0  43.6 111.9  38.9* 82.0  31.6**†† 
TP (ms2) 12251  9277 7782  5963** 4123  4057**†† 
VLF (ms2) 3658  3516 3171  2918 1915  2206**†† 
LF (ms2) 3197  2798 2584  2861 1529  1247**† 
LF (nu) 40.86  19.35 53.48  18.30** 72.80  13.50**†† 
HF (ms2) 5073  6287 1904  1779** 621  858**†† 
HF (nu) 55.98  18.93 43.26  18.15** 24.47  13.27**†† 
LF/HF 1.15  1.51 2.18  3.61** 4.77  4.49**†† 
TV (L) 0.64  0.27 0.67  0.36 0.76  0.38 
RR (breaths·min-1) 13.58  3.77 14.04  3.66 15.26  3.83**†† 
V E (L·min-1) 6.78  1.78 7.27  2.28 8.92  2.79**
††
 
V O2 (mL·kg-1·min-1) 3.96  0.87 3.86  1.12 4.73  1.35**
††
 




p<0.01 vs. Seated; HR, heart rate; SDNN, 
standard deviation of RR (NN) intervals; SDΔNN, standard deviation of the change in RR intervals; RMSSD, 
square root of the mean squared differences of successive RR intervals; SD1, standard deviation of instantaneous 
RR variability; SD2, standard deviation of long-term RR variability; TP, total power; VLF, very low frequency; 
LF, low frequency; nu, normalised units; HF, high frequency; LF/HF, low frequency to high frequency ratio; 
TV, tidal volume; RR, respiratory rate; V E, ventilation; V O2, oxygen uptake. 
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Table 5  Heart rate variability and respiratory variables during consecutive 10-minute periods of 
supine, seated and standing rest (n=30). 
 Time (minutes) 






2014  1169 
2083  1623 
1445  1304** 
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 p<0.01 vs. 0-10; 
VLF, very low frequency; V E, ventilation; V O2, oxygen uptake. 
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Table 6  Heart rate variability and respiratory variables for male and female participants during rest. 
 Male 
(n=14) 
        Female 
         (n=16) 
HR (bpm)          64.7  12.6       73.0  17.3
‡
 
SDNN (ms)          93.5  37.2       75.6  33.3* 
SDΔNN (ms)          71.0  42.1       62.3  50.0 
RMSSD (ms)          70.8  41.8       62.7  49.9 
SD1 (ms)          50.2  29.7       44.0  35.4 
SD2 (ms)        121.3  46.0       95.7  36.1* 
TP (ms2)         9681  7459      6627  7337* 
VLF (ms2)         3873  3771      2076  1762* 
LF (ms2)         3186  2762      1782  2060** 
LF (nu)        61.62  19.04     50.54  22.50* 
HF (ms2)         2422  2724      2629  5210 
HF (nu)        35.83  18.96     45.96  22.17
‡
 
LF/HF          3.50  4.82       2.00  2.26* 
TV (L) 0.86  0.38 0.54  0.21*** 
RR (breaths·min-1)        13.50  3.96     14.99  3.54 
V E (L·min-1)          8.94  2.41       6.54  1.96*** 
V O2 (mL·kg-1·min-1)          4.54  1.09       3.88  1.19* 
Values are mean  SD; 
‡
p≤0.06, *p<0.05, **p<0.01, ***p<0.001 vs. Male; HR, heart rate; SDNN, 
standard deviation of RR (NN) intervals; SDΔNN, standard deviation of the change in RR intervals; 
RMSSD, square root of the mean squared differences of successive RR intervals; SD1, standard 
deviation of instantaneous RR variability; SD2, standard deviation of long-term RR variability; TP, 
total power; VLF, very low frequency; LF, low frequency; nu, normalised units; HF, high frequency; 
LF/HF, low frequency to high frequency ratio; TV, tidal volume; RR, respiratory rate; V E, ventilation; 
V O2, oxygen uptake. 
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Table 7  Reliability measures including intraclass correlation coefficients (CV, %) for consecutive 10-minute heart rate variability and respiratory 
variables for male and female participants during supine, seated and standing rest (n=14 male, n=16 female). 
 Supine Seated Standing 
 Male Female Male Female Male Female 
HR (bpm) 0.911 (2.8) 0.980 (2.4) 0.913 (3.1) 0.942 (3.0) 0.967 (2.4) 0.946 (3.6) 
SDNN (ms) 0.813 (15.5) 0.851 (11.6) 0.899 (11.9) 0.712 (13.9) 0.897 (12.3) 0.731 (11.2) 
SDΔNN (ms) 0.925 (11.2) 0.956 (8.9) 0.886 (12.5) 0.808 (15.6) 0.943 (13.1) 0.640 (16.8) 
RMSSD (ms) 0.922 (11.4) 0.956 (8.9) 0.886 (12.4) 0.809 (15.6) 0.943 (13.1) 0.368 (23.8) 
SD1 (ms) 0.927 (11.2) 0.956 (8.9) 0.886 (12.5) 0.808 (15.6) 0.943 (13.1) 0.640 (16.7) 
SD2 (ms) 0.744 (17.9) 0.739 (14.1) 0.895 (12.8) 0.670 (14.7) 0.887 (12.4) 0.733 (11.2) 
TP (ms
2
) 0.828 (29.5) 0.830 (24.3) 0.868 (28.4) 0.700 (32.1) 0.889 (27.8) 0.620 (28.5) 
VLF (ms
2
) 0.731 (46.0) 0.098* (53.6) 0.808 (43.2) 0.358 (45.9) 0.839 (34.9) 0.583 (34.8) 
LF (ms
2
) 0.729 (34.6) 0.864 (32.5) 0.825 (35.8) 0.734 (39.5) 0.829 (30.8) 0.587 (35.1) 
LF (nu) 0.699 (19.9) 0.865 (24.0) 0.651 (15.3) 0.709 (21.3) 0.819 (7.1) 0.723 (10.6) 
HF (ms
2
) 0.820 (29.9) 0.931 (20.7) 0.819 (36.4) 0.734 (38.4) 0.933 (31.7) 0.546 (40.7) 
HF (nu) 0.718 (17.3) 0.858 (12.0) 0.664 (25.4) 0.724 (19.3) 0.843 (19.1) 0.721 (26.9) 
LF/HF 0.721 (38.2) 0.854 (35.7) 0.731 (43.8) 0.703 (41.4) 0.888 (25.7) 0.738 (36.3) 
TV (L) 0.881 (8.8) 0.902 (8.1) 0.962 (7.3) 0.942 (10.5) 0.954 (6.7) 0.912 (9.1) 
RR (breaths∙min
-1
) 0.944 (8.0) 0.901 (6.6) 0.943 (6.1) 0.877 (7.4) 0.965 (5.3) 0.909 (6.1) 
V E (L∙min-1) 0.909 (8.4) 0.861 (6.3) 0.850 (7.9) 0.902 (11.0) 0.918 (6.5) 0.922 (8.2) 
V O2 (ml∙kg-1∙min-1) 0.932 (5.9) 0.855 (5.9) 0.899 (6.0) 0.923 (9.8) 0.895 (6.3) 0.932 (9.0) 
p<0.001 for all variables except *not-significant; scale for correlation coefficient - 0=low, 1=very high; HR, heart rate; SDNN, standard deviation of RR (NN) 
intervals; SDΔNN, standard deviation of the change in RR intervals; RMSSD, square root of the mean squared differences of successive RR intervals; SD1, standard 
deviation of instantaneous RR variability; SD2, standard deviation of long-term RR variability; TP, total power; VLF, very low frequency; LF, low frequency; nu, 
normalised units; LF/HF, low frequency to high frequency ratio; TV, tidal volume; RR, respiratory rate; V E, ventilation. V O2, oxygen uptake. 
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Figure 1  Stability of consecutive 10-minute heart rate variability measures during 40-minutes of 
rest (n=30).  HR heart rate; SDNN, standard deviation of RR (NN) intervals; SDΔNN, standard 
deviation of the change in RR intervals; RMSSD, square root of the mean squared differences of 
successive RR intervals; SD1, standard deviation of instantaneous RR variability; SD2, standard 
deviation of long-term RR variability; TP, total power; VLF, very low frequency; LF, low 
frequency; nu, normalised units; HF, high frequency; LF/HF, low frequency to high frequency ratio. 

